NEO - NeoGenomics Inc
NeoGenomics Inc Logo

NEO - NeoGenomics Inc

https://www.neogenomics.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.

52W High
$19.11
52W Low
$4.72
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.62
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
222.22
EV/EBITDA (<8 favorable)
-27.92
EV/Revenue (<3 favorable)
1.86
P/S (TTM) (<3 favorable)
1.50
P/B (<3 favorable)
1.21
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
1.29%
Institutions (25–75% balanced)
100.36%
Shares Outstanding
129,179,000
Float
119,993,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
689,189,000
Gross Profit (TTM)
302,241,000
EPS (TTM)
-0.82
Profit Margin (>10% good)
-0.15%
Operating Margin (TTM) (higher better)
-0.15%
ROE (TTM) (>15% strong)
-0.12%
EPS YoY (Quarterly) (>10% good)
1.31
Revenue YoY (Quarterly) (>8% good)
0.10
Momentum
Bearish momentum
Value
0.5356
Previous
0.5607
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025